Cattle and Goat Tuberculosis Antibodies Rapid Test Kit (Colloidal gold) |
abx092019-40tests |
Abbexa |
40 tests |
EUR 585.6 |
|
Igg Antibody Laboratories manufactures the igg antibodies test for cov-id 19 reagents distributed by Genprice. The Igg Antibodies Test For Cov-Id 19 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Igg products are available in stock. Specificity: Igg Category: Antibodies Group: Test For
SARS-CoV-2 (COVID-19) Nucleocapsid Antibody |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |
SARS-CoV-2 (COVID-19) Nucleocapsid Antibody |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |
SARS-CoV-2 (COVID-19) Nucleocapsid Antibody |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |
SARS-CoV-2 (COVID-19) Nucleocapsid Antibody |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
SARS-CoV-2 (COVID-19) Membrane Antibody |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
Test For information
Human HIV(1+2 antibodies ) (3rd Generation) ELISA Kit |
EH4100 |
FN Test |
96T |
EUR 571.5 |
|
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative |
Human Anti-Basiliximab (Simulect) IgG (Anti-drug antibodies/ADA) ELISA Kit for human, 96 tests, quantitative |
210-330-ABG |
Alpha Diagnostics |
1 kit |
EUR 1365.6 |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Tetanus vaccines (Toxin/Toxoid) by ELISA |
930-090-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Classical Swine Fever Virus Antibodies Rapid Test Kit (Colloidal gold) |
abx092020-50tests |
Abbexa |
50 tests |
EUR 385.2 |
|
Human Anti-Daclizumab (Zenapax) IgG (Anti-drug antibodies/ADA) ELISA Kit for human, 96 tests, quantitative |
210-310-ADG |
Alpha Diagnostics |
1 kit |
EUR 1365.6 |
Human Anti-Eculizumab (Soliris) IgG (Anti-drug antibodies/ADA) ELISA Kit for human, 96 tests, quantitative |
210-410-AEG |
Alpha Diagnostics |
1 Kit |
EUR 1365.6 |
Cattle and Goat Tuberculosis Antibodies Rapid Test Kit (Colloidal gold) |
abx092019-40tests |
Abbexa |
40 tests |
EUR 585.6 |
|
TruStrip RDT 5-Minute rapid test to confirm the presence of humanized antibodies, 10 tests/pk |
1750-RDT-10 |
Alpha Diagnostics |
1 kit |
EUR 424.8 |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to S. enterica serovar Typhi (Typhoid) by ELISA |
990-500-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Ebola/Marburg Virus Protein (NP/GP/VP40) ELISA |
AE-320520-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Peste des Petits Ruminants Virus Antibodies Rapid Test Kit (Colloidal gold) |
abx092018-50tests |
Abbexa |
50 tests |
EUR 585.6 |
|
ELISA kit for Human anti-Beta2 glycoprotein I antibodies IgG (Beta2-GP1 IgG) |
KTE62929-48T |
Abbkine |
48T |
EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human anti-Beta2 glycoprotein I antibodies IgG (Beta2-GP1 IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human anti-Beta2 glycoprotein I antibodies IgG (Beta2-GP1 IgG) |
KTE62929-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2702.4 |
Description: Quantitative sandwich ELISA for measuring Human anti-Beta2 glycoprotein I antibodies IgG (Beta2-GP1 IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human anti-Beta2 glycoprotein I antibodies IgG (Beta2-GP1 IgG) |
KTE62929-96T |
Abbkine |
96T |
EUR 686.4 |
Description: Quantitative sandwich ELISA for measuring Human anti-Beta2 glycoprotein I antibodies IgG (Beta2-GP1 IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Wolbachia Surface Proteins (WSP/WSP26) by ELISA |
RV-403500-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Meninigitis Vaccines (Group A/C/Y/W) by ELISA |
600-300-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Human Anti-Erbitux (Cetuximab/C225/IMC225) IgG (Anti-drug antibodies/ADA) ELISA Kit for human, 96 tests, quantitative |
210-110-AEG |
Alpha Diagnostics |
1 kit |
EUR 1365.6 |